Pengaruh Puguntano (Curanga Fel-Terrae Merr.) terhadap HOMA-IR pada Pasien Diabetes Mellitus Baru
39
DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care. 2013; 36: 67–74.
2. PERKENI (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, dkk.
Homeostasis model assessment of insulin resistance for evaluating insulin
sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine
Journal. 2013; 60(3): 283-290.
4. Taylor R. Insulin Resistance and Type 2 Diabetes. DIABETES. 2012; 61.
5. Tara MW, Jonathan C, David R. Use and Abuse of HOMA Modeling.
Diabetes Care. 2004; 27: 1487–1495,
6. Gayoso-diz P, Alfonso, Maria. Insulin resistance (HOMA-IR) cut-off values
and the metabolic syndrome in a general adult population: effect of gender and
age: EPIRCE cross-sectional study. BMC Endocrine Disorders. 2013, 13: 47.
7. Depkes RI. (2000). Inventaris Tanaman Obat Indonesia (I). Cetakan Pertama.
Jakarta: Departemen Kesehatan RI. Halaman 21-22.
8. Plant Resources of South-East Asia. 2012. Medicinal and poisonous 2.
PRSEA. 2012; 12(2).
9. Harfina F, Bahri S, Saragih A. Pengaruh serbuk daun Puguntano (Curanga felterrae Merr.) pada pasien Diabetes Mellitus. Journal of Pharmaceutics and
Pharmacology. 2012; 1 (2): 112-118.
10. Juwita NA. Pengujian efek antiinflamasi ekstrak etanol daun pugun tano
(Curanga fel-terrae Merr.) terhadap mencit putih. Medan: Fakultas Farmasi
USU. 2009.
11. SP3T. Uji antidiabetes dari daun pugun tano (Curanga fel-terrae Merr) yang
digunakan masyarakat dairi secara preklinis. Sentra Pengembangan dan
Penerapan Pengobatan Tradisional (SP3T). Medan. 2011.
12. Harahap U, Patilaya P, Mariane, dkk. Profil fitokimia ekstrak etanol daun
puguntano [curanga fel-terrae (merr.) lour.] yang berpotensi sebagai antiasma.
Seminar Nasional Sains & Teknologi V Lembaga Penelitian Universitas
Lampung. 2013.
Universitas Sumatera Utara
40
13. Sitorus P, Harahap U, Pandapotan M, Barus T. Isolation of β-sitosterol from
n-Hexane Extract of Picria fel-terrae Lour. Leave and Study of Its Antidiabetic
Effect in Alloxan Induced Diabetic Mice. International Journal of PharmTech
Research. 2014; 6(1): 137-141.
14. Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev. 2005 May. 2005;
26(2): 19-39.
15. Shulman GI. Cellular Mechanisms of Insulin Resistance. The Journal of
Clinical Investigation. 2000; 106: 2.
16. Sheperd PR, Kahn BB. Glucose Transporter and Insulin Action. The New
England Journal of Medicine. 1999.
17. Hui-Qi Qu, Quan Li, Fisher-Hoch. The definition of insulin resistance using
homa-ir for americans of mexican descent using machine learning. PLOS ONE
2011; 6(6): e2104.
18. Subramanian V, Butler LG, Jambunathan R. Some agronomic and
biochemical characters of brown sorghums and their possible role in bird
resistance. J Agric Food Chem. 1983; 31: 1303-1307.
19. Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Arvedol A. Grape
seedderived procyanidins have an antihyperglycemic effect in streptozotocininduced diabetic rats and insulinomimetic activity in insulin- sensitive cell
lines. Endocrinology. 2004; 145: 4985-4990.
20. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food
intake by green tea epigallocatechin gallate. Endocrinology. 2000; 141: 980987.
21. Kim MJ, Ryu GR, Chung JS, Sim SS. Protective effects of epicatechin against
the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro.
Pancreas. 2003; 26: 292-299.
22. Anderson RA dan Polansky MM. Tea enhances insulin activity. J Agric Food
Chem. 2002; 50: 7182-7186.
23. Bennick A. Interaction of plant polyphenols with salivary proteins. Crit Rev
Oral Bio Me. 2002; 13: 184-196.
24. Kumari M dan Jain S. Tannins: An Antinutrient with Positive Effect to
Manage Diabetes. Res J Recent Sci. 2012; 1(12): 70-73.
Universitas Sumatera Utara
41
25. Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA,
Paladini AC, et al. Central nervous system depressant action of flavonoid
glycosides. Eur J Pharmacol. 2006; 539(3): 168–176.
26. Patra JC dan Chua BH. Artificial neutral network based drug design for
diabetes mellitus using flavonoids. J Comput Chem. 2010; 32(4): 555–567.
27. Mohan S dan Nandhakumar L. Role of various flavonoids: Hypotheses on
novel approach to treat diabetes. Journal of Medical Hypotheses and Ideas.
2013; 8: 1–6.
28. Brahmachari G. Bio-flavonoids with promising antidiabetic potentials: A
critical survey. Opportunity, Challenge and Scope of Natural Products in
Medicinal Chemistry. 2011: 187-212.
29. Matsuda H, Morikawa T, Yoshikawa M. Pure Appl. Chem. 2002; 74: 13011308.
30. Petrash JM. All in the family: aldose reductase and closely related aldo-keto
reductases. Cell. Mol. Life Sci. 2004; 61(7-8): 737-749.
31. Pradip K , Vasumathi T , Marina K. Antidiabetic effect and mode of action of
the triterpenoid, cddo-me, in diet-induced type 2 diabetic mice and lepr
db/db
mice. ADA. 2010: 1393-1397.
32. Atanasov AG, Wang JN, Gu SP, Bu J. A non-adipogenic PPARγ agonist from
nature. Biochim Biophys Acta. 2013; 1830(10): 4813-4819.
33. Madiyono B. Perkiraan Besar Sampel dalam Dasar-dasar Metodologi
Penelitian Klinis. Sastroasmoro S, Ismael S. Jakarta: Sagung Seto 2008; 16:
302-330.
34. Katsuki A, Sumida Y, Gabazza CE, Murashima S, Furuta M, Araki R.
Homeostasis model assessment is a reliable indicator of insulin resistance
during follow-up of patients with type 2 diabetes. Diabetes Care. 2001; 24:
362–365.
35. Rojas LBA, Gomes MB. Metformin: an old but still the best treatment for type
2 diabetes. Diabetology & Metabolic Syndrome. 2013; 5: 6.
36. Iliadis F, Kadoglou NP, Hatzitolios A, Karamouzis M, Alevizos M,
Karamitsos D. Metabolic effects of rosiglitazone and metformin in Greek
Universitas Sumatera Utara
42
patients with recently diagnosed type 2 diabetes. In vivo journal. 2007; 21:
1107-1114.
37. Ma J, Liu LY, Wu PH, Liao Y, Tao T, Liu W. Comparison of metformin and
repaglinide monotherapy in the Treatment of new onset type 2 diabetes
mellitus in china. Journal of Diabetes Research. 2014.
38. Krysiak R, Gdula-Dymek A, Okopien B. Effect of metformin on selected
parameters of hemostasis in fenofibrate-treated patients with impaired glucose
tolerance. Pharmacological Reports. 2013; 65: 208- 213.
39. Kadhim KA, Ismael DK, Khalaf BH, Husseiun KL, Zalzala MH, Hussain SA.
Dose-dependent relationship between serum metformin levels and glycemic
control, insulin resistance and leptin levels in females newly diagnosed with
type 2 diabetes mellitus. Journal of Diabetes Mellitus. 2012; 2: 179-185.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care. 2013; 36: 67–74.
2. PERKENI (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, dkk.
Homeostasis model assessment of insulin resistance for evaluating insulin
sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine
Journal. 2013; 60(3): 283-290.
4. Taylor R. Insulin Resistance and Type 2 Diabetes. DIABETES. 2012; 61.
5. Tara MW, Jonathan C, David R. Use and Abuse of HOMA Modeling.
Diabetes Care. 2004; 27: 1487–1495,
6. Gayoso-diz P, Alfonso, Maria. Insulin resistance (HOMA-IR) cut-off values
and the metabolic syndrome in a general adult population: effect of gender and
age: EPIRCE cross-sectional study. BMC Endocrine Disorders. 2013, 13: 47.
7. Depkes RI. (2000). Inventaris Tanaman Obat Indonesia (I). Cetakan Pertama.
Jakarta: Departemen Kesehatan RI. Halaman 21-22.
8. Plant Resources of South-East Asia. 2012. Medicinal and poisonous 2.
PRSEA. 2012; 12(2).
9. Harfina F, Bahri S, Saragih A. Pengaruh serbuk daun Puguntano (Curanga felterrae Merr.) pada pasien Diabetes Mellitus. Journal of Pharmaceutics and
Pharmacology. 2012; 1 (2): 112-118.
10. Juwita NA. Pengujian efek antiinflamasi ekstrak etanol daun pugun tano
(Curanga fel-terrae Merr.) terhadap mencit putih. Medan: Fakultas Farmasi
USU. 2009.
11. SP3T. Uji antidiabetes dari daun pugun tano (Curanga fel-terrae Merr) yang
digunakan masyarakat dairi secara preklinis. Sentra Pengembangan dan
Penerapan Pengobatan Tradisional (SP3T). Medan. 2011.
12. Harahap U, Patilaya P, Mariane, dkk. Profil fitokimia ekstrak etanol daun
puguntano [curanga fel-terrae (merr.) lour.] yang berpotensi sebagai antiasma.
Seminar Nasional Sains & Teknologi V Lembaga Penelitian Universitas
Lampung. 2013.
Universitas Sumatera Utara
40
13. Sitorus P, Harahap U, Pandapotan M, Barus T. Isolation of β-sitosterol from
n-Hexane Extract of Picria fel-terrae Lour. Leave and Study of Its Antidiabetic
Effect in Alloxan Induced Diabetic Mice. International Journal of PharmTech
Research. 2014; 6(1): 137-141.
14. Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev. 2005 May. 2005;
26(2): 19-39.
15. Shulman GI. Cellular Mechanisms of Insulin Resistance. The Journal of
Clinical Investigation. 2000; 106: 2.
16. Sheperd PR, Kahn BB. Glucose Transporter and Insulin Action. The New
England Journal of Medicine. 1999.
17. Hui-Qi Qu, Quan Li, Fisher-Hoch. The definition of insulin resistance using
homa-ir for americans of mexican descent using machine learning. PLOS ONE
2011; 6(6): e2104.
18. Subramanian V, Butler LG, Jambunathan R. Some agronomic and
biochemical characters of brown sorghums and their possible role in bird
resistance. J Agric Food Chem. 1983; 31: 1303-1307.
19. Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Arvedol A. Grape
seedderived procyanidins have an antihyperglycemic effect in streptozotocininduced diabetic rats and insulinomimetic activity in insulin- sensitive cell
lines. Endocrinology. 2004; 145: 4985-4990.
20. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food
intake by green tea epigallocatechin gallate. Endocrinology. 2000; 141: 980987.
21. Kim MJ, Ryu GR, Chung JS, Sim SS. Protective effects of epicatechin against
the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro.
Pancreas. 2003; 26: 292-299.
22. Anderson RA dan Polansky MM. Tea enhances insulin activity. J Agric Food
Chem. 2002; 50: 7182-7186.
23. Bennick A. Interaction of plant polyphenols with salivary proteins. Crit Rev
Oral Bio Me. 2002; 13: 184-196.
24. Kumari M dan Jain S. Tannins: An Antinutrient with Positive Effect to
Manage Diabetes. Res J Recent Sci. 2012; 1(12): 70-73.
Universitas Sumatera Utara
41
25. Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA,
Paladini AC, et al. Central nervous system depressant action of flavonoid
glycosides. Eur J Pharmacol. 2006; 539(3): 168–176.
26. Patra JC dan Chua BH. Artificial neutral network based drug design for
diabetes mellitus using flavonoids. J Comput Chem. 2010; 32(4): 555–567.
27. Mohan S dan Nandhakumar L. Role of various flavonoids: Hypotheses on
novel approach to treat diabetes. Journal of Medical Hypotheses and Ideas.
2013; 8: 1–6.
28. Brahmachari G. Bio-flavonoids with promising antidiabetic potentials: A
critical survey. Opportunity, Challenge and Scope of Natural Products in
Medicinal Chemistry. 2011: 187-212.
29. Matsuda H, Morikawa T, Yoshikawa M. Pure Appl. Chem. 2002; 74: 13011308.
30. Petrash JM. All in the family: aldose reductase and closely related aldo-keto
reductases. Cell. Mol. Life Sci. 2004; 61(7-8): 737-749.
31. Pradip K , Vasumathi T , Marina K. Antidiabetic effect and mode of action of
the triterpenoid, cddo-me, in diet-induced type 2 diabetic mice and lepr
db/db
mice. ADA. 2010: 1393-1397.
32. Atanasov AG, Wang JN, Gu SP, Bu J. A non-adipogenic PPARγ agonist from
nature. Biochim Biophys Acta. 2013; 1830(10): 4813-4819.
33. Madiyono B. Perkiraan Besar Sampel dalam Dasar-dasar Metodologi
Penelitian Klinis. Sastroasmoro S, Ismael S. Jakarta: Sagung Seto 2008; 16:
302-330.
34. Katsuki A, Sumida Y, Gabazza CE, Murashima S, Furuta M, Araki R.
Homeostasis model assessment is a reliable indicator of insulin resistance
during follow-up of patients with type 2 diabetes. Diabetes Care. 2001; 24:
362–365.
35. Rojas LBA, Gomes MB. Metformin: an old but still the best treatment for type
2 diabetes. Diabetology & Metabolic Syndrome. 2013; 5: 6.
36. Iliadis F, Kadoglou NP, Hatzitolios A, Karamouzis M, Alevizos M,
Karamitsos D. Metabolic effects of rosiglitazone and metformin in Greek
Universitas Sumatera Utara
42
patients with recently diagnosed type 2 diabetes. In vivo journal. 2007; 21:
1107-1114.
37. Ma J, Liu LY, Wu PH, Liao Y, Tao T, Liu W. Comparison of metformin and
repaglinide monotherapy in the Treatment of new onset type 2 diabetes
mellitus in china. Journal of Diabetes Research. 2014.
38. Krysiak R, Gdula-Dymek A, Okopien B. Effect of metformin on selected
parameters of hemostasis in fenofibrate-treated patients with impaired glucose
tolerance. Pharmacological Reports. 2013; 65: 208- 213.
39. Kadhim KA, Ismael DK, Khalaf BH, Husseiun KL, Zalzala MH, Hussain SA.
Dose-dependent relationship between serum metformin levels and glycemic
control, insulin resistance and leptin levels in females newly diagnosed with
type 2 diabetes mellitus. Journal of Diabetes Mellitus. 2012; 2: 179-185.
Universitas Sumatera Utara